This Site contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Delcath Systems, Inc. is not obligated to update the press releases and information contained in this section of the Site.
| # |
Article Title |
Date |
| 1 |
DELCATH SYSTEMS ANNOUNCES COMPLETION OF COMMON STOCK OFFERING | Wednesday, 25 August 2010 |
| 2 |
DELCATH SYSTEMS ANNOUNCES THE SALE OF 5,185,000 SHARES OF COMMON STOCK | Monday, 16 August 2010 |
| 3 |
DELCATH TO PRESENT AT THE 30TH ANNUAL CANACCORD GLOBAL GROWTH CONFERENCE | Wednesday, 4 August 2010 |
| 4 |
Delcath To Present At The 2010 WEDBUSH Securities Life Sciences Best Ideas Management Access Conference |
Wednesday, 28 July 2010 |
| 5 |
Delcath Systems Announces Second Quarter Progress Report Conference Call |
Monday, 26 July 2010 |
| 6 |
DOUGLAS G. WATSON, FORMER CEO OF NOVARTIS CORPORATION, JOINS DELCATH BOARD OF DIRECTORS |
Tuesday, 13 July 2010 |
| 7 |
Delcath Systems To Conduct Conference Call To Discuss Recent Corporate Developments |
Friday, 11 June 2010 |
| 8 |
Delcath Highlights Phase III Trial Results Presented at ASCO |
Saturday, 5 June 2010 |
| 9 |
Delcath Systems, Inc. To Participate At Upcoming Investor Conferences |
Wednesday, 26 May 2010 |
| 10 |
Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago
|
Wednesday, 19 May 2010 |
| 11 |
Delcath Systems Appoints Peter J. Graham as Executive Vice President and General Counsel |
Thursday, 22 April 2010 |
| 12 |
Delcath Phase III Trial Results Exceed Primary Endpoint Expectations
|
Wednesday, 21 April 2010 |
| 13 |
Delcath’s Phase III Trial Data to be Presented During American Society of Clinical Oncology 2010 Annual Meeting in Chicago |
Tuesday, 13 April 2010 |
| 14 |
Delcath Systems Provides Update on Corporate Developments |
Friday, 12 March 2010 |
| 15 |
Delcath Systems Names Michael D. Dellario as Vice President, Global Marketing |
Monday, 1 March 2010 |
| 16 |
Delcath Systems to Conduct Conference Call to Update Investors on Recent Progress |
Friday, 26 February 2010 |
| 17 |
Delcath Systems, Inc. to Participate at Upcoming Investor Conferences |
Thursday, 25 February 2010 |
| 18 |
Delcath to Initiate Expanded Access Treatment Program for PHP System With Melphalan |
Tuesday, 16 February 2010 |
| 19 |
Delcath Signs First Partner Agreement in Asia |
Tuesday, 09 February 2010 |
| 20 |
Delcath Systems Begins Data Analysis of Phase III Trial |
Thursday, 04 February 2010 |
| 21 |
Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference |
Tuesday, 12 January 2010 |
| 22 |
Professor Riccardo Lencioni Joins Delcath Systems’ Scientific Advisory Board |
Tuesday, 22 December 2009 |
| 23 |
Delcath Systems, Inc. Sponsors Satellite Session at World Meeting of Melanoma/Skin Cancer Centers |
Tuesday, 24 November 2009 |
| 24 |
Delcath Systems Reports Substantial Progress |
Thursday, 19 November 2009 |
| 25 |
Delcath Systems to Present at Lazard Capital Markets 6th Annual Healthcare Conference |
Monday, 16 November 2009 |
| 26 |
Delcath Systems, Inc. Prices $30.6 Million Stock Offering |
Friday, 13 November 2009 |
| 27 |
Delcath Systems, Inc. Announces Public Offering of Common Stock |
Tuesday, 27 October 2009 |
| 28 |
Delcath Systems Completes Executive Management Team with Strategic New Hires
|
Friday, 23 October 2009 |
| 29 |
Delcath Systems, Inc. Completes Phase III Study Enrollment |
Wednesday, 21 October 2009 |
| 30 |
Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer |
Friday, 02 October 2009 |
| 31 |
Delcath Systems, Inc. Appoints David McDonald Chief Financial Officer |
Monday, 14 September 2009 |
| 32 |
Data Safety Monitoring Board Unanimously Recommends Continuation of Delcath's Phase III Clinical Trial |
Friday, 11 September 2009 |
| 33 |
Delcath Systems, Inc. to Present Poster at International Liver Cancer Association 2009 Annual Conference |
Friday, 04 September 2009 |
| 34 |
Delcath Systems to Present at Renshaw 11th Annual Healthcare Conference
|
Friday, 04 September 2009 |
| 35 |
Delcath Establishes Queensbury, NY Operations Facility |
Thursday, 03 September 2009 |
| 36 |
FDA Grants Delcath Orphan–Drug Designation for Doxorubicin |
Monday, 31 August 2009 |
| 37 |
Delcath Systems, Inc. Announces Patient Recruitment Exceeds 90% |
Tuesday, 25 August 2009 |
| 38 |
Delcath Systems to Present at Canaccord Adams 29th Annual Global Growth Conference |
Monday, 10 August 2009 |